These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25044689)

  • 1. Skin-resident CD4+ T cells express NK receptors: lessons from skin pathologies.
    Brooks AE
    Cytometry A; 2014 Oct; 85(10):827-9. PubMed ID: 25044689
    [No Abstract]   [Full Text] [Related]  

  • 2. Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin.
    Sako N; Schiavon V; Bounfour T; Dessirier V; Ortonne N; Olive D; Ram-Wolff C; Michel L; Sicard H; Marie-Cardine A; Bagot M; Bensussan A; Schmitt C
    Cytometry A; 2014 Oct; 85(10):869-82. PubMed ID: 25044837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD158k/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides.
    Ortonne N; Le Gouvello S; Tabak R; Marie-Cardine A; Setiao J; Berrehar F; Nghe-Tang A; Martin N; Bagot M; Bensussan A
    Exp Dermatol; 2012 Jun; 21(6):461-3. PubMed ID: 22621189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased CD160 expression on circulating natural killer cells in atherogenesis.
    Zuo J; Shan Z; Zhou L; Yu J; Liu X; Gao Y
    J Transl Med; 2015 Jun; 13():188. PubMed ID: 26071079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells.
    Moins-Teisserenc H; Daubord M; Clave E; Douay C; Félix J; Marie-Cardine A; Ram-Wolff C; Maki G; Beldjord K; Homyrda L; Michel L; Bensussan A; Toubert A; Bagot M
    J Invest Dermatol; 2015 Jan; 135(1):247-257. PubMed ID: 25158034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation.
    Abecassis S; Giustiniani J; Meyer N; Schiavon V; Ortonne N; Campillo JA; Bagot M; Bensussan A
    J Invest Dermatol; 2007 May; 127(5):1161-6. PubMed ID: 17218942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma.
    Battistella M; Janin A; Jean-Louis F; Collomb C; Leboeuf C; Sicard H; Bonnafous C; Dujardin A; Ram-Wolff C; Kadin ME; Bensussan A; Bagot M; Michel L
    Br J Dermatol; 2016 Aug; 175(2):325-33. PubMed ID: 27037558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome.
    Poszepczynska-Guigné E; Schiavon V; D'Incan M; Echchakir H; Musette P; Ortonne N; Boumsell L; Moretta A; Bensussan A; Bagot M
    J Invest Dermatol; 2004 Mar; 122(3):820-3. PubMed ID: 15086570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased co-expression of the natural killer cell receptor NKG2D and further natural killer cell receptors on CD4⁺ T cells in granulomatosis with polyangiitis.
    Schüler S; Wolters S; Pitann S; Kabelitz D; Lamprecht P
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-183-4. PubMed ID: 26016770
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-positive CD4/CD8 mycosis fungoides: a rarely reported immunohistochemical profile.
    Tournier E; Laurent C; Thomas M; Meyer N; Viraben R; Brousset P; Lamant L
    J Cutan Pathol; 2014 Jan; 41(1):58-62. PubMed ID: 24134789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Vitiligo or Hypopigmented Mycosis Fungoides?
    Gomez-Moyano E; Vera-Casaño A; Gamero AH; Sanz-Trelles A; Crespo-Erchiga V
    J Pediatr Hematol Oncol; 2010 May; 32(4):338-9. PubMed ID: 20418787
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation.
    Giustiniani J; Bensussan A; Marie-Cardine A
    J Immunol; 2009 Jan; 182(1):63-71. PubMed ID: 19109136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIR3DL2/CpG ODN interaction mediates Sézary syndrome malignant T cell apoptosis.
    Ghazi B; Thonnart N; Bagot M; Bensussan A; Marie-Cardine A
    J Invest Dermatol; 2015 Jan; 135(1):229-237. PubMed ID: 25007046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier.
    Del Rio ML; Bravo Moral AM; Fernandez-Renedo C; Buhler L; Perez-Simon JA; Chaloin O; Alvarez Nogal R; Fernandez-Caso M; Rodriguez-Barbosa JI
    Transl Res; 2017 Mar; 181():83-95.e3. PubMed ID: 27702550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CD160 binding to HVEM triggers an inhibitory signal to the activated T cell].
    Bensussan A
    Med Sci (Paris); 2008 Apr; 24(4):361-2. PubMed ID: 18405629
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of the CD4+ cell-specific chemoattractant interleukin-16 in mycosis fungoides.
    Blaschke V; Reich K; Middel P; Letschert M; Sachse F; Harwix S; Neumann C
    J Invest Dermatol; 1999 Oct; 113(4):658-63. PubMed ID: 10504456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycosis fungoides with focal CD 30 transformation in an adolescent.
    Romero M; Haney M; Desantis E; Zlotoff B
    Pediatr Dermatol; 2008; 25(5):565-8. PubMed ID: 18950403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human and mouse mast cells express and secrete the GPI-anchored isoform of CD160.
    Ortonne N; Ram-Wolff C; Giustiniani J; Marie-Cardine A; Bagot M; Mecheri S; Bensussan A
    J Invest Dermatol; 2011 Apr; 131(4):916-24. PubMed ID: 21191401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of interleukin IL-2 and IL-12 + IL-18 on surface expression of immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in natural killer cells.
    Chrul S; Polakowska E; Szadkowska A; Bodalski J
    Mediators Inflamm; 2006; 2006(4):46957. PubMed ID: 17047292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.